EDX Medical Group PLC (LSE:EDX) Share Price

Company Profile

Business description
EDX Medical Group PLC is principally engaged in the business of creating health testing solutions and developing biological and digital technologies to improve the detection of diseases and disorders. It develops and provides digital diagnostic products and services for testing in areas including cancer, cardiovascular disease, neurology, and infectious diseases. It operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development and provides testing and genomic sequencing services. It has two operating segments: Medical goods and Medical services. The majority of revenue is generated from the Medical services segment. Geographically, all revenue was derived from the United Kingdom.
Contact
Milton Road
211 Cambridge Science Park
CambridgeCB4 0WA
GBR
https://www.edxmedical.co.uk
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2027
Employees
15

Recommended

Near-term pain, long-term potential.

Dan Baker | 22 October 2026

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.

Malik Ahmed Khan, CFA | 22 October 2026

Our increased valuation comes from higher full self-driving adoption assumptions and a lower near- and medium-term capital expenditures forecast.

Seth Goldstein, CFA | 22 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,905.80	11.30	-0.13%
CAC 40	7,811.26	110.42	-1.39%
DAX 40	25,371.75	273.29	-1.07%
Dow JONES (US)	52,867.98	11.89	0.02%
FTSE 100	10,725.03	27.85	-0.26%
HKSE	23,076.96	142.28	0.62%
NASDAQ	26,008.86	694.00	-2.60%
Nikkei 225	62,527.74	380.10	-0.60%
NZX 50 Index	13,733.93	12.91	-0.09%
S&P 500	7,663.43	93.74	-1.21%
S&P/ASX 200	8,795.20	2.00	0.02%
SSE Composite Index	3,641.59	16.43	-0.45%